Skip to main content
. 2020 Aug 28;10:100. doi: 10.1186/s13550-020-00678-2

Table 2.

Average SUVmean values obtained at 60 min post-injection of [18F]FSPG and [18F]FDG for each of the cancer types

Head and neck cancer Colorectal cancer Non-Hodgkin lymphoma
SUV 60 min p.i. (g/ml) [18F]FSPG [18F]FDG Ratio SUVFSPG/SUVFDG [18F]FSPG [18F]FDG Ratio SUVFSPG/SUVFDG [18F]FSPG [18F]FDG Ratio SUVFSPG/SUVFDG
(mean ± SD) (mean ± SD) (mean ± SD)
Primary 2.8 ± 2.1 4.9 ± 2.2 0.57 5.4 ± 1.3 6.9 ± 0.8 0.78 1.9 ± 3.1 1.9 ± 1.6 1.00
Metastases 1.3 ± 0.7 3.0 ± 1.4 0.43 2.5 ± 2.4 3.5 ± 3.5 0.71 - -
Aorta 0.8 ± 0.3 1.6 ± 0.3 0.50 0.9 ± 0.4 1.9 ± 0.5 0.47 1.0 ± 0.3 1.7 ± 0.3 0.59
Pancreas 7.4 ± 1.4 1.7 ± 0.2 4.35 7.0 ± 1.4 1.7 ± 0.4 4.12 7.1 ± 1.7 1.9 ± 0.3 3.74
Heart 0.7 ± 0.1 2.4 ± 1.3 0.29 0.8 ± 0.4 3.9 ± 1.5 0.21 0.9 ± 0.1 2.0 ± 0.5 0.45
Kidney whole 9.8 ± 1.3 3.2 ± 0.6 3.06 16.1 ± 7.3 4.7 ± 2.6 3.43 11.4 ± 2.7 4.4 ± 1.4 2.59
Kidney cortex 8.2 ± 0.6 2.6 ± 0.1 3.15 11.3 ± 3.7 2.8 ± 1.0 4.04 10.6 ± 2.8 2.7 ± 0.4 3.93
Brain 0.1 ± 0.0 7.9 ± 1.4 0.01 0.12 ± 0.04 7.8 ± 2.0 0.01 0.1 ± 0.0 8.2 ± 3.6 0.01
Muscle 0.2 ± 0.04 0.7 ± 0.1 0.29 0.2 ± 0.1 0.6 ± 0.1 0.33 0.3 ± 0.1 0.8 ± 0.1 0.38
Lung 0.2 ± 0.04 0.4 ± 0.1 0.50 0.3 ± 0.1 0.5 ± 0.2 0.60 0.3 ± 0.1 0.5 ± 0.2 0.60
Liver 1.2 ± 0.3 2.3 ± 0.2 0.52 1.5 ± 0.4 2.3 ± 0.3 0.65 1.5 ± 0.1 2.6 ± 0.3 0.58
Tumor: brain 27.6 0.6 46.00 45.3 0.9 50.33 18.9 0.2 94.50
Tumor: aorta 3.3 3.0 1.10 5.7 3.7 1.54 1.9 1.1 1.73
Tumor: muscle 12.6 7.2 1.75 20.9 11.2 1.87 6.7 2.5 2.68
Tumor: liver 2.3 2.2 1.05 3.7 3.0 1.23 1.3 0.8 1.63
Tumor: pancreas 0.4 2.9 0.14 0.8 1.7 0.47 0.3 1 0.30
Tumor: kidney 0.3 1.5 0.20 3.4 1.5 2.27 0.2 0.4 0.50

The tumor-to-background ratios are also shown and were taken with respect to six different relevant backgrounds: brain, aorta (blood pool), muscle (left gluteal muscle), liver, pancreas, and kidney